Cargando…
Development and validation of a model to determine risk of refractory benign esophageal strictures
BACKGROUND: Current research has identified several risk factors for refractory benign esophageal strictures (RBES), but research is scarce on the prediction of RBES in benign esophageal strictures patients. Meanwhile, the long-term outcomes of RBES remain unclear. The aim of this study was to devel...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658380/ https://www.ncbi.nlm.nih.gov/pubmed/31367621 http://dx.doi.org/10.12998/wjcc.v7.i13.1623 |
_version_ | 1783438953904340992 |
---|---|
author | Lu, Qing Lei, Tian-Tian Wang, Yi-Lan Yan, Hai-Lin Lin, Bo Zhu, Lin-Lin Ma, Hong-Sheng Yang, Jin-Lin |
author_facet | Lu, Qing Lei, Tian-Tian Wang, Yi-Lan Yan, Hai-Lin Lin, Bo Zhu, Lin-Lin Ma, Hong-Sheng Yang, Jin-Lin |
author_sort | Lu, Qing |
collection | PubMed |
description | BACKGROUND: Current research has identified several risk factors for refractory benign esophageal strictures (RBES), but research is scarce on the prediction of RBES in benign esophageal strictures patients. Meanwhile, the long-term outcomes of RBES remain unclear. The aim of this study was to develop and validate a model to determine the progression of RBES in patients with benign esophageal strictures. And we also explored the long-term outcomes and safety in patients with RBES. AIM: To develop and validate a model to determine the progression of RBES in patients with benign esophageal strictures, based on the demographic data and endoscopic findings. METHODS: A total of 507 benign esophageal stricture patients treated by dilation alone or in combination with stenting were retrospectively enrolled between January 2009 and February 2018. The primary outcome was to establish a risk-scoring model predicting RBES in benign esophageal strictures. The secondary outcome was to explore the clinical effectiveness and adverse events in patients with RBES. RESULTS: In the study, age, etiology, and number and length of strictures were the independent risk factors for the refractory performance of benign esophageal strictures. According to risk factors of benign esophageal strictures, a risk-scoring model for predicting RBES in benign esophageal strictures was established: The risk score ranged from 0 to 8 points, and the risk scores were divided into low risk (0-2 points), intermediate risk (3-5 points), and high risk (6-8 points). The proportions of RBES in the corresponding risk categories were 1.0%, 12.2%, and 76.0%, respectively. Among 507 patients, 57 had RBES (39 males; median age, 60 years). The success rate of dilation treatment (51.2%, 21/41) was higher than that of stent placement (37.5%, 6/16). CONCLUSION: In this study, 11.3% (57/507) patients had RBES at our hospital. The risk-scoring model predicting RBES in benign esophageal strictures could predict the long-term outcome of patients with strictures ahead. |
format | Online Article Text |
id | pubmed-6658380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-66583802019-07-31 Development and validation of a model to determine risk of refractory benign esophageal strictures Lu, Qing Lei, Tian-Tian Wang, Yi-Lan Yan, Hai-Lin Lin, Bo Zhu, Lin-Lin Ma, Hong-Sheng Yang, Jin-Lin World J Clin Cases Clinical Trials Study BACKGROUND: Current research has identified several risk factors for refractory benign esophageal strictures (RBES), but research is scarce on the prediction of RBES in benign esophageal strictures patients. Meanwhile, the long-term outcomes of RBES remain unclear. The aim of this study was to develop and validate a model to determine the progression of RBES in patients with benign esophageal strictures. And we also explored the long-term outcomes and safety in patients with RBES. AIM: To develop and validate a model to determine the progression of RBES in patients with benign esophageal strictures, based on the demographic data and endoscopic findings. METHODS: A total of 507 benign esophageal stricture patients treated by dilation alone or in combination with stenting were retrospectively enrolled between January 2009 and February 2018. The primary outcome was to establish a risk-scoring model predicting RBES in benign esophageal strictures. The secondary outcome was to explore the clinical effectiveness and adverse events in patients with RBES. RESULTS: In the study, age, etiology, and number and length of strictures were the independent risk factors for the refractory performance of benign esophageal strictures. According to risk factors of benign esophageal strictures, a risk-scoring model for predicting RBES in benign esophageal strictures was established: The risk score ranged from 0 to 8 points, and the risk scores were divided into low risk (0-2 points), intermediate risk (3-5 points), and high risk (6-8 points). The proportions of RBES in the corresponding risk categories were 1.0%, 12.2%, and 76.0%, respectively. Among 507 patients, 57 had RBES (39 males; median age, 60 years). The success rate of dilation treatment (51.2%, 21/41) was higher than that of stent placement (37.5%, 6/16). CONCLUSION: In this study, 11.3% (57/507) patients had RBES at our hospital. The risk-scoring model predicting RBES in benign esophageal strictures could predict the long-term outcome of patients with strictures ahead. Baishideng Publishing Group Inc 2019-07-06 2019-07-06 /pmc/articles/PMC6658380/ /pubmed/31367621 http://dx.doi.org/10.12998/wjcc.v7.i13.1623 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Clinical Trials Study Lu, Qing Lei, Tian-Tian Wang, Yi-Lan Yan, Hai-Lin Lin, Bo Zhu, Lin-Lin Ma, Hong-Sheng Yang, Jin-Lin Development and validation of a model to determine risk of refractory benign esophageal strictures |
title | Development and validation of a model to determine risk of refractory benign esophageal strictures |
title_full | Development and validation of a model to determine risk of refractory benign esophageal strictures |
title_fullStr | Development and validation of a model to determine risk of refractory benign esophageal strictures |
title_full_unstemmed | Development and validation of a model to determine risk of refractory benign esophageal strictures |
title_short | Development and validation of a model to determine risk of refractory benign esophageal strictures |
title_sort | development and validation of a model to determine risk of refractory benign esophageal strictures |
topic | Clinical Trials Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658380/ https://www.ncbi.nlm.nih.gov/pubmed/31367621 http://dx.doi.org/10.12998/wjcc.v7.i13.1623 |
work_keys_str_mv | AT luqing developmentandvalidationofamodeltodetermineriskofrefractorybenignesophagealstrictures AT leitiantian developmentandvalidationofamodeltodetermineriskofrefractorybenignesophagealstrictures AT wangyilan developmentandvalidationofamodeltodetermineriskofrefractorybenignesophagealstrictures AT yanhailin developmentandvalidationofamodeltodetermineriskofrefractorybenignesophagealstrictures AT linbo developmentandvalidationofamodeltodetermineriskofrefractorybenignesophagealstrictures AT zhulinlin developmentandvalidationofamodeltodetermineriskofrefractorybenignesophagealstrictures AT mahongsheng developmentandvalidationofamodeltodetermineriskofrefractorybenignesophagealstrictures AT yangjinlin developmentandvalidationofamodeltodetermineriskofrefractorybenignesophagealstrictures |